Regulaxis SAS: A French startup that develops regenerative solutions based on new synthetic peptides

0
The scope of regenerative treatments in the medical sector is growing with new methods and innovative solutions. French startup Regulaxis SAS is a biotech company that does research, development, and licensing of innovative synthetic molecules for human therapies. The startup has gained much recognition for its pathbreaking new treatment for osteoarthritis by regenerating knee cartilage. Regulaxis SAS was one of…
« Previous post: | Next post: »